Cargando…
Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment
Although biologically targeted therapies based on key oncogenic mutations have made significant progress in the treatment of locally advanced or metastatic thyroid cancer, the challenges of drug resistance are urging us to explore other potentially effective targets. Herein, epigenetic modifications...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142462/ https://www.ncbi.nlm.nih.gov/pubmed/37111316 http://dx.doi.org/10.3390/ph16040559 |